TrialBone marrow transplantation2022

Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial.

Fanny Rialland et al.PubMed ↗Publisher ↗

No numbers read from the abstract.